Peer-reviewedCC BY 4.0Trials
The effect of a low-iodine diet on remission and quality of life in newly diagnosed patients with Graves’ disease: the ELODI superiority, parallel group randomized controlled trial protocol
Related
- Incidence of diabetes remission and association with microvascular and macrovascular complications in patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study using real-world data in Thailand.
- Effectiveness of virtual reality exposure therapy in improving body dissatisfaction and shape-related concerns in adolescent girls with anorexia nervosa: a controlled, randomized, superiority trial.
- Protocol of the PANEM trial: A randomized, phase III, parallel-arm, placebo-controlled, double-blind, multi-center superiority trial comparing PANcreatic EnzyMes versus placebo in adults after gastrectomy
- Optimizing threat expectancy change during exposure therapy for anxiety disorders: Study protocol for a mechanism-focused two-arm parallel group randomized controlled superiority trial with sequential Bayes factor design
- Protocol for a parallel-group superiority randomized controlled trial comparing Sage- a couple psychotherapy- to supportive individual psychotherapy for borderline personality disorder.
BibTeX
@article{weesjansen2026effect,
title = {{The effect of a low-iodine diet on remission and quality of life in newly diagnosed patients with Graves’ disease: the ELODI superiority, parallel group randomized controlled trial protocol}},
author = {Elsbeth R. P. C. van Wees-Jansen and Barbara A. Hutten and Max Nieuwdorp},
journal = {Trials},
year = {2026},
month = nov,
doi = {10.1186/s13063-026-10079-w},
url = {https://link.springer.com/article/10.1186/s13063-026-10079-w},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The effect of a low-iodine diet on remission and quality of life in newly diagnosed patients with Graves’ disease: the ELODI superiority, parallel group randomized controlled trial protocol
AU - Elsbeth R. P. C. van Wees-Jansen
AU - Barbara A. Hutten
AU - Max Nieuwdorp
PY - 2026
DA - 2026/11/09
JO - Trials
DO - 10.1186/s13063-026-10079-w
UR - https://link.springer.com/article/10.1186/s13063-026-10079-w
SN - 1745-6215
ER -